Analyzing...
Loading company...
Rubicon Research Ltd is a pharmaceutical research and development company engaged in drug development, contract research, and manufacturing. It provides end-to-end services to global pharmaceutical clients, from early-stage discovery to clinical trials and regulatory support. Its capabilities include formulation development, bioanalytical studies, and manufacturing of active pharmaceutical ingredients. The company leverages its scientific expertise to deliver innovative and reliable solutions to the healthcare industry.
No significant concerns identified
Nothing flagged for monitoring
“Operates in Pharmaceuticals — Formulations & API.”
₹1,306 Cr revenue.
COGS 32.1%, employees 12.6%.
“revenues have grown 39% year on year, operating EBITDA grew 53% and PAD was 56% higher than the previous year.”
“we are confident of keeping the operating EBITDA in the range of 22 to 23%.”
“data was at INR112 crores, which was up by 59%”
| KPI | Company | Sector Median |
|---|---|---|
| ROE | 13.9%▲ | 10.3% |
| ROCE | 18.7%▲ | 13.7% |
| Net Margin | 14.3%▲ | 7.6% |
| EBITDA Margin | 24.4%▲ | 15.4% |
| Debt To Equity | 0.19x▲ | 0.15x |
Historical valuation data not available.
Revenue segment breakdown not available.
| (₹ Cr) | TTM |
|---|---|
| Revenue | ₹1,306 Cr |
| Other Income | ₹11 Cr |
| Total Income | ₹1,317 Cr |
| COGS | ₹420 Cr |
| ₹1,064 Cr | |
| Profit Before Tax | ₹253 Cr |
| ₹65 Cr | |
| Net Profit | ₹188 Cr |
| Other Comprehensive Income | (₹0.80 Cr) |
| EPS | ₹11.40 |
| Diluted Shares | ₹17 Cr |
No related party data available for this company.
This section will be populated when data becomes available.
Rubicon Research Limited has informed the Exchange about Copy of Newspaper Publication
Rubicon Research Limited has informed the Exchange regarding 'Communication on tax deduction at source on Dividend '.
Filing of Scheme of Merger of Kia Health Tech Private Limited (Wholly Owned Subsidiary) with Rubicon Research Limited For Disclosure Purposes Only, in terms of the Exemption under Paragraph 4 of SEB...
Rubicon Research Limited has informed the Exchange regarding a press release dated July 22, 2026, titled "Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) R...
Rubicon Research Limited has informed the Exchange that Record date for the purpose of Dividend is 07-Aug-2026.
Rubicon Research Limited has informed the Exchange regarding Outcome of Board Meeting held on July 20, 2026.1. Date of 27th Annual General Meeting and Record Date for payment of final dividend on equi...
Rubicon Research Limited has informed the Exchange regarding 'Allotment of ESOPs'.
Rubicon Research Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Rubicon Research Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) read with Regulation 31(5) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 201...
Rubicon Research Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regul...
Rubicon Research Limited has informed the Exchange regarding 'Audio Recording of earnings call'.
Rubicon Research Limited has informed the Exchange about Copy of Newspaper Publication
Rubicon Research Limited has informed the Exchange about General Updates
Rubicon Research Limited has informed the Exchange about General Updates
Rubicon Research Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Disclaimer · The Stock Filter is an information platform, not a SEBI-registered investment adviser. All data, scores, and narratives are generated from public filings and AI analysis — they do not constitute investment advice, recommendations, or endorsements. Always consult a qualified financial adviser before making investment decisions. Past performance does not guarantee future results.
No dividend history available for this company.